Melatonin Reverses the Profibrillogenic Activity of Apolipoprotein E4 on the Alzheimer Amyloid Aβ Peptide
- 15 November 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 40 (49) , 14995-15001
- https://doi.org/10.1021/bi0114269
Abstract
Inheritance of apoE4 is a strong risk factor for the development of late-onset sporadic Alzheimer's disease (AD). Several lines of evidence suggest that apoE4 binds to the Alzheimer Aβ protein and, under certain experimental conditions, promotes formation of β-sheet structures and amyloid fibrils. Deposition of amyloid fibrils is a critical step in the development of AD. We report here that addition of melatonin to Aβ in the presence of apoE resulted in a potent isoform-specific inhibition of fibril formation, the extent of which was far greater than that of the inhibition produced by melatonin alone. This effect was structure-dependent and unrelated to the antioxidant properties of melatonin, since it could be reproduced neither with the structurally related indole N-acetyl-5-hydroxytryptamine nor with the antioxidants ascorbate, α-tocophenol, and PBN. The enhanced inhibitory effects of melatonin and apoE were lost when bovine serum albumin was substituted for apoE. In addition, Aβ in combination with apoE was highly neurotoxic (apoE4 > apoE3) to neuronal cells in culture, and this activity was also prevented by melatonin. These findings suggest that reductions in brain melatonin, which occur during aging, may contribute to a proamyloidogenic microenvironment in the aging brain.Keywords
This publication has 14 references indexed in Scilit:
- Inhibition of Alzheimer β-Fibrillogenesis by MelatoninJournal of Biological Chemistry, 1998
- CorrespondenceTrends in Neurosciences, 1998
- The Interaction between Apolipoprotein E and Alzheimer's Amyloid β-Peptide Is Dependent on β-Peptide ConformationJournal of Biological Chemistry, 1996
- Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's diseaseAnnals of Neurology, 1996
- Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structureNeuroscience Letters, 1995
- Amyloid β binding proteins in vitro and in normal human cerebrospinal fluidNeuroscience Letters, 1995
- Characterization of Apolipoprotein J-Alzheimer's Aβ InteractionPublished by Elsevier ,1995
- Morning bright light therapy for sleep and behavior disorders in elderly patients with dementiaActa Psychiatrica Scandinavica, 1994
- Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's diseaseJournal of Molecular Biology, 1991
- Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killJournal of Immunological Methods, 1989